Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183225336> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2183225336 endingPage "6" @default.
- W2183225336 startingPage "631" @default.
- W2183225336 abstract "Pharmacokinetic and biodistribution studies were conducted in rats on a novel serine protease inhibitor, LEX 032, that was radiolabeled with 131I by the Bolton-Hunter reagent. LEX 032, a genetically engineered recombinant human nonglycosylated serpin, has been shown to have antiinflammatory properties in a number of animal models of inflammation and reperfusion injury. When 131I-LEX 032 was injected intravenously, a rapid whole body clearance of radioactivity was seen. Blood clearance followed a similar pattern. Forty-eight hours postinjection, 2.00 +/- 0.65 of the administered dose remained in the body. Greater than 59% of the radio-activity was excreted in the urine within the first 24 hr. Little radioactivity was found in the feces. With the exception of the thyroid, no significant organ-related uptake was noted. Radioactivity in the liver peaked at 20 min postinjection, with 1.00 +/- 0.13% administered dose/g and approximately 10% administered dose in the whole liver. At 1 hr, uptake in the kidney (9.30 +/- 1.52% administered dose/g) was the highest among all tissues, except for the thyroid. Gamma camera images were consistent with the biodistribution pattern. Pharmacokinetics and biodistribution were not affected by the dose of LEX 032 and were quite different from those of glycosylated wild type antichymotrypsin. These data indicate that LEX 032 exhibits the pharmacokinetics expected of a nonglycosylated 45 kDa protein." @default.
- W2183225336 created "2016-06-24" @default.
- W2183225336 creator A5015618426 @default.
- W2183225336 creator A5017725276 @default.
- W2183225336 creator A5024068437 @default.
- W2183225336 creator A5031523200 @default.
- W2183225336 creator A5065585246 @default.
- W2183225336 creator A5079299908 @default.
- W2183225336 creator A5086803031 @default.
- W2183225336 date "1997-05-01" @default.
- W2183225336 modified "2023-09-27" @default.
- W2183225336 title "Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin." @default.
- W2183225336 cites W1519781060 @default.
- W2183225336 cites W1557007841 @default.
- W2183225336 cites W15795119 @default.
- W2183225336 cites W1582715471 @default.
- W2183225336 cites W1986028457 @default.
- W2183225336 cites W2002708696 @default.
- W2183225336 cites W2019924357 @default.
- W2183225336 cites W2033136853 @default.
- W2183225336 cites W2038669374 @default.
- W2183225336 cites W2100837269 @default.
- W2183225336 cites W2101108802 @default.
- W2183225336 cites W2107873069 @default.
- W2183225336 cites W2183353764 @default.
- W2183225336 cites W2253542933 @default.
- W2183225336 cites W2406334126 @default.
- W2183225336 cites W2408312684 @default.
- W2183225336 cites W258376682 @default.
- W2183225336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9152604" @default.
- W2183225336 hasPublicationYear "1997" @default.
- W2183225336 type Work @default.
- W2183225336 sameAs 2183225336 @default.
- W2183225336 citedByCount "0" @default.
- W2183225336 crossrefType "journal-article" @default.
- W2183225336 hasAuthorship W2183225336A5015618426 @default.
- W2183225336 hasAuthorship W2183225336A5017725276 @default.
- W2183225336 hasAuthorship W2183225336A5024068437 @default.
- W2183225336 hasAuthorship W2183225336A5031523200 @default.
- W2183225336 hasAuthorship W2183225336A5065585246 @default.
- W2183225336 hasAuthorship W2183225336A5079299908 @default.
- W2183225336 hasAuthorship W2183225336A5086803031 @default.
- W2183225336 hasConcept C104317684 @default.
- W2183225336 hasConcept C112705442 @default.
- W2183225336 hasConcept C126322002 @default.
- W2183225336 hasConcept C134018914 @default.
- W2183225336 hasConcept C181389837 @default.
- W2183225336 hasConcept C185592680 @default.
- W2183225336 hasConcept C202751555 @default.
- W2183225336 hasConcept C2777807558 @default.
- W2183225336 hasConcept C2780091579 @default.
- W2183225336 hasConcept C40767141 @default.
- W2183225336 hasConcept C55493867 @default.
- W2183225336 hasConcept C71924100 @default.
- W2183225336 hasConcept C98274493 @default.
- W2183225336 hasConceptScore W2183225336C104317684 @default.
- W2183225336 hasConceptScore W2183225336C112705442 @default.
- W2183225336 hasConceptScore W2183225336C126322002 @default.
- W2183225336 hasConceptScore W2183225336C134018914 @default.
- W2183225336 hasConceptScore W2183225336C181389837 @default.
- W2183225336 hasConceptScore W2183225336C185592680 @default.
- W2183225336 hasConceptScore W2183225336C202751555 @default.
- W2183225336 hasConceptScore W2183225336C2777807558 @default.
- W2183225336 hasConceptScore W2183225336C2780091579 @default.
- W2183225336 hasConceptScore W2183225336C40767141 @default.
- W2183225336 hasConceptScore W2183225336C55493867 @default.
- W2183225336 hasConceptScore W2183225336C71924100 @default.
- W2183225336 hasConceptScore W2183225336C98274493 @default.
- W2183225336 hasIssue "5" @default.
- W2183225336 hasLocation W21832253361 @default.
- W2183225336 hasOpenAccess W2183225336 @default.
- W2183225336 hasPrimaryLocation W21832253361 @default.
- W2183225336 hasRelatedWork W1971607352 @default.
- W2183225336 hasRelatedWork W2020959757 @default.
- W2183225336 hasRelatedWork W2038782216 @default.
- W2183225336 hasRelatedWork W2042033030 @default.
- W2183225336 hasRelatedWork W2069436261 @default.
- W2183225336 hasRelatedWork W2165824272 @default.
- W2183225336 hasRelatedWork W2279994500 @default.
- W2183225336 hasRelatedWork W2586846067 @default.
- W2183225336 hasRelatedWork W2591911969 @default.
- W2183225336 hasRelatedWork W2907033774 @default.
- W2183225336 hasVolume "25" @default.
- W2183225336 isParatext "false" @default.
- W2183225336 isRetracted "false" @default.
- W2183225336 magId "2183225336" @default.
- W2183225336 workType "article" @default.